Table 2b.
Cortex plasmalogen mass in SSADH deficient patient and control group
| nmol/g ww | mol % | |||||
|---|---|---|---|---|---|---|
|
|
||||||
| Patient | Mean (control) | SD | Patient | Mean (control) | SD | |
|
|
||||||
| EtnGpl | 11536 | 7311 | 598* | 41.1% | 41.6% | 6.4% |
| PlsEtn | 16563 | 10424 | 1861* | 58.9% | 58.4% | 6.4% |
| ChoGpl | 19621 | 13233 | 1479* | 92.0% | 90.6% | 0.9% |
| PlsCho | 1698 | 1379 | 195 | 8.0% | 9.4% | 0.9% |
| n = 1 | n = 4 | |||||
Mass values are expressed as nmol phosphorus/gram wet weight tissue and represent mean±SD of control and patient values. Molar composition values are expressed as mol % of total phosphorus. n = 2–4.
indicates significance between patient and control group, 2 SD from control mean.